Advanced Accelerator Applications S.A.

France

Commandez votre montre hebdomadaire Advanced Accelerator Applications S.A.
Quantité totale PI 40
Quantité totale incluant filiales 65 (+ 25 pour les filiales)
Rang # Quantité totale PI 35 775
Note d'activité PI 2,4/5.0    29
Rang # Activité PI 26 588
Activité incl filiales 2,2/5.0    39

Brevets

Marques

34 0
6 0
0 0
0
 
Dernier brevet 2025 - Method of treating cancer by int...
Premier brevet 2006 - Escherichia coli

Filiales

3 subsidiaries with IP (25 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2025 Invention Method of treating cancer by intratumoral deposition of radioactive microparticles. A compositio...
Invention Stable, concentrated radionuclide complex solutions. Stable, concentrated radionuclide complex s...
2024 Invention Stable, concentrated radionuclide complex solutions. The present invention relates to radionucli...
Invention Neutron activator, neutron activation system comprising such neutron activator and method for neu...
Invention Accelerator-drivenneutron activator for bachytherapy. A neutron activator for neutron activation...
Invention Stable, concentrated radionuclide complex solutions. The present invention relates to radionuclid...
Invention Method of treatment of neuroendocrine tumors. The present invention relates to methods of treati...
2023 Invention Accelerator-driven neutron activator for brachytherapy. A neutron activator for neutron activati...
2022 Invention Combination therapy for treating lung cancer. The present invention relates to methods for treat...
Invention Method of treatment of neuroendocrine tumors that over-express somatostatatin receptors. The pre...
2021 Invention Method for producing high purity and high specific activity radionuclides. The invention relates...
2019 Invention Neutron activator includes a metallic plate target configured to produce protons through interact...
2018 Invention New nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precurs...
Invention Accelerator-driven neutron activator for brachytherapy. a Beryllium first reflector-moderator (4)...
2017 Invention Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors ...
2014 Invention Compounds modulators of vegf activity and uses thereof. Compounds of general formula (1): X1Y1X2Y...
2013 Invention Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio) molecules; precursors...
Invention 3 receptor peptide antagonist for therapeutic and diagnostic applications. 3-targeted therapy and...
2010 Invention Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use th...
Invention Use of microrna-199b-5p in medical and diagnostic field. This invention concerns the use of Micro...
2009 Invention Dicarba-analogues of octreotide. Analogues of octreotide, their preparation and use are described.
Invention Peptides and their use as carriers into cancer cells. The use of a peptide is described as a carr...
2007 Invention Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ...
2006 Invention Selective αvβ3 receptor peptide antagonist for therapeutic and diagnostic applications. 3-targete...
Invention Escherichia coli . Escherichia coli. Escherichia coli to an industrial level.